Investor mix
19 investors on record; lead investors include CDH, SDIC, Panlin Capital, Korea Investment Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 47% |
| Private equity | 4 | 21% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 4 | 21% |
Developed of drugs for the treatment of cancer
19 investors on record; lead investors include CDH, SDIC, Panlin Capital, Korea Investment Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 47% |
| Private equity | 4 | 21% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 4 | 21% |